Monday, May 27, 2013
Another busy IPO week,
headlined by the largest offering since 2011, suggests the new offerings window
has opened at last, at least in the U.S. Two companies priced their offerings,
three set their price ranges and four jumped in line with filings.
The sector has seen several
strong quarters of public market financings, including $2.3 billion raised by
biotechs via 31 follow-on deals in 1Q13. However, companies and investors have
been waiting for an IPO window to materialize (see BioCentury, April 1).